Hepion Pharmaceuticals, Inc.（HEPA）内部人交易：高管与董事近期交易
过去 18 个月，共有 6 位内部人为 Hepion Pharmaceuticals, Inc.（HEPA）报告了 12 笔 Form 4 交易（最近一笔 2026-10-02）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-02 | Fisher Danina | 董事 | 买入 | 200,000 | $10,000 |
| 2026-08-12 | Stetz Gary S. | Interim CEO | 买入 | 2.0M | $100,000 |
| 2026-08-12 | LoPriore Vincent S | Executive Chairman | 买入 | 8.0M | $400,000 |
| 2026-08-12 | Purcell Michael J. | 董事 | 买入 | 2.0M | $100,000 |
| 2026-08-12 | Appajosyula Sireesh | Chief Operating Officer | 买入 | 2.0M | $100,000 |
| 2026-08-12 | Stetz Gary S. II | 董事 | 买入 | 500,000 | $25,000 |
| 2026-08-12 | LoPriore Vincent S | Executive Chairman | 买入 | 2.0M | $100,000 |
| 2026-04-27 | LoPriore Vincent S | Executive Chairman | 买入 | 5.0M | $200,000 |
| 2026-04-27 | LoPriore Vincent S | Executive Chairman | 买入 | 1.2M | $50,000 |
| 2026-04-27 | Stetz Gary S. | Interim CEO | 买入 | 1.2M | $50,000 |
| 2026-04-27 | Appajosyula Sireesh | 董事 | 买入 | 1.2M | $50,000 |
| 2026-04-27 | Purcell Michael J. | 董事 | 买入 | 1.2M | $50,000 |
来源：SEC Form 4 申报文件 · 截至 2026-10-02